Cross-Border Investments in US Healthcare Firms

Cross-border investments in US healthcare firms regulatory and market analysis

Cross-border investment into US healthcare firms has intensified as global capital seeks exposure to innovation-driven growth, regulatory stability, and large-scale commercialization opportunities. The United States remains the largest healthcare market globally, underpinned by strong intellectual property protections, mature capital markets, and a well-defined regulatory framework led by the Food and Drug Administration. These factors collectively … Read more